A patient symptoms of functional and cognitive decline, dyskinesia and depression surprisingly resolve after a suicide attempt.

Depression, Extrapyramidal Symptoms, Dementia and an Unexpected Outcome: A Case Report Magda Tsolaki; Chaido Z Messini; Marianna Siapera; Foteini Fotiadou; Dionysia Delaporta; Athanasios Karatolias ...

Mental illness cost Imtiaz Zafar almost a decade of his academic life. Now it motivates him to help find effective treatments ...

Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat ...

Acute extrapyramidal side effects after using metoclopramide are harmless and reversible, but undoubtedly a dramatic and unpleasant experience for patients. It is essential to be aware that the ...

Background: One of the core clinical features of dementia with Lewy bodies (DLB) is extrapyramidal syndrome (EPS). Levodopa is currently the gold standard oral therapy for Parkinson’s disease (PD), ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...

Randomised clinical trials comparing haloperidol with olanzapine for people with schizophrenia and schizophrenia-spectrum disorders. Our main outcomes of interest were clinically important change in ...

Detailed price information for Neumora Therapeutics Inc (NMRA-Q) from The Globe and Mail including charting and trades.